Bitcoin's price increased by 0.59% within an hour on October 5, moving from $86,052 to $86,564. During this period, $13.96 million in short positions were liquidated across Binance, Bybit, and OKX, while only $10,000 in long positions were liquidated. This significant liquidation of shorts indicates strong buying pressure on Bitcoin. The data reflects activity on these three exchanges and does not cover the entire cryptocurrency market.
Bitcoin's recent price movement and liquidation activity provide context for broader cryptocurrency trends. For readers following crypto markets, here is Pluang's snapshot as of Oct 05, 2026 05:02 WIB: out of 50 major cryptocurrencies, 32 rose and 16 fell today. Notably, XTZ gained 4.71% with 74% sell orders, contrasting with DOGE which rose 4.15% but had 75% buy orders, while ONE dropped 7.63% with a majority of sell activity at 56%.
Binance liquidated a single Bitcoin short position worth $2.56 million on its perpetual futures market at a price of $86,567. This liquidation occurred on October 4 at 6:16 p.m. ET and involved closing a short trade, which profits from price declines...
France's Schneider Electric is close to acquiring US software company PTC for about $20 billion, according to the Financial Times. The deal could be announced as soon as Monday, though discussions are still ongoing and not guaranteed. PTC, based in B...
This week in crypto was volatile with Bitcoin briefly surpassing $87k before dropping below $84k. Citi raised its 12-month Bitcoin price target to $113k, signaling bullish sentiment. Among altcoins, Midnight (NIGHT) surged 85%, showing strong accumul...
Oracle has committed $10 million and formed a strategic partnership to support the Nashville Symphony as it restructures. This investment will help the orchestra address its immediate financial challenges, resume its 2026-27 season, and bring back fu...
CSL and Alentis Therapeutics have formed an exclusive global partnership to co-develop and co-promote lixudebart, a novel therapy targeting claudin-1 for kidney and liver diseases. CSL will pay Alentis $355 million upfront and up to $1.2 billion in m...
